Outlook Therapeutics (OTLK) Non-Current Debt (2015 - 2026)
Outlook Therapeutics (OTLK) recorded Non-Current Debt of $11.12 million in fiscal Q2 2026 (quarter ended Mar 31, 2026), down 47.1% from $21.05 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Non-Current Debt (2015 - 2026) Analysis & Trends
At the end of FY2021 (ended Sep 30, 2021), Outlook Therapeutics reported Non-Current Debt of $10.89 million.
- Annual Non-Current Debt has a five-year compound annual growth rate of 37.3% (FY2016 to FY2021).
- Across earlier fiscal years, Non-Current Debt came in at $904,200 in FY2020, $50,285 in FY2019 (-48.9%), $98,487 in FY2018 (-99.3%) and $13.23 million in FY2017 (+492.3%).
- The fiscal Q2 2026 figure is the lowest quarterly Non-Current Debt since fiscal Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 11.12 Mn |
| Jun 30, 2025 | 20.44 Mn |
| Mar 31, 2025 | 21.05 Mn |
| Dec 31, 2022 | 31.82 Mn |
| Dec 31, 2021 | 9.60 Mn |
| Sep 30, 2021 | 10.89 Mn |
| Mar 31, 2021 | 129,171.00 |
| Dec 31, 2020 | 10.66 Mn |
| Sep 30, 2020 | 904,200.00 |
| Jun 30, 2020 | 544,924.00 |
| Mar 31, 2020 | 25,709.00 |
| Dec 31, 2019 | 38,011.00 |
| Sep 30, 2019 | 50,285.00 |
| Jun 30, 2019 | 62,856.00 |
| Mar 31, 2019 | 75,073.00 |
| Dec 31, 2018 | 86,947.00 |
| Sep 30, 2018 | 98,487.00 |
| Jun 30, 2018 | 111,541.00 |
| Mar 31, 2018 | 127,787.00 |
| Dec 31, 2017 | 143,488.00 |
API Access
Outlook Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();